AC Immune SA
ACIU
$2.93
-$0.03-0.85%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -58.48M | -57.96M | -57.96M | -57.22M |
| Total Depreciation and Amortization | -- | 2.65M | 2.50M | 2.50M | 2.46M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 2.45M | 9.60M | 9.60M | 7.74M |
| Change in Net Operating Assets | -- | 3.94M | 96.09M | 96.09M | 119.36M |
| Cash from Operations | -- | -49.43M | 50.23M | 50.23M | 72.33M |
| Capital Expenditure | -- | -1.15M | -775.80K | -775.80K | -657.90K |
| Sale of Property, Plant, and Equipment | -- | 18.20K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 26.69M | -86.47M | -86.47M | -116.90M |
| Cash from Investing | -- | 25.55M | -87.24M | -87.24M | -117.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -851.00K | -769.00K | -769.00K | -683.00K |
| Issuance of Common Stock | -- | 3.00K | 135.00K | 135.00K | 137.00K |
| Repurchase of Common Stock | -- | -26.00K | -26.00K | -26.00K | -26.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.00K | -30.00K | -30.00K | -548.00K |
| Cash from Financing | -- | -1.01M | -779.90K | -779.90K | -1.28M |
| Foreign Exchange rate Adjustments | -- | -4.01M | -4.12M | -4.12M | -1.83M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -28.91M | -41.91M | -41.91M | -48.34M |